Saez J M, Dazord A, Morera A M, Bataille P
J Biol Chem. 1975 Mar 10;250(5):1683-9.
Crude membranes (20,000 times g pellet) prepared from human, rat, and ovine adrenals bind 125-I-corticotropin-(1-24)-tetracosapeptide (125-I-ACTH-1-24) and degrade unbound hormone. The degradation is dependent on temperature and the concentration of membrane proteins. The degradation of 125-I-[9-tryptophan(o-nitrophenylsulfenyl)]-corticotropin-(1-24)-tetracosapeptide (125-I-NPS-ACTH-1-24) is similar to 125-I-ACTH-1-24, but that of 125-I-corticotropin-(11-24)-tetradecapeptide (125-I-ACTH-1-24 is inhibited by ACTH-1-24 and corticotropin-(1-10)-decapeptide (ACTH-1-10), but ACTH-11-24 at the same molar concentration has no effect. On the other hand, the degradation of 125-I-ACTH-11-24 is protected by ACTH-11-24 and ACTH-1-24, but not by ACTH-1-10. This suggests two systems of degradation, one will have the NH-2-terminal sequence of ACTH-1-24 as substrate, and the other the 11-24 COOH-terminal sequence. The main label product from the degradation of the 125-I-ACTH-1-24 and 125-I-ACTH-11-24 behaves as [125-I]monoiodotyrosine on Sephadex G-50 and paper chromatography. The independence of ACTH binding to its receptor and degradation is demonstrated by the following facts. (a) Calcium and pancreatic trypsin inhibitor completely inhibit the binding at concentrations when the degradation is not altered; (b) the sequences of peptides of ACTH which inhibit the binding and degradation of 125-I-ACTH-1-24 are different.
从人、大鼠和绵羊肾上腺制备的粗制膜(20,000倍重力沉降物)能结合125I-促肾上腺皮质激素-(1-24)-二十四肽(125I-ACTH-1-24)并降解未结合的激素。这种降解依赖于温度和膜蛋白的浓度。125I-[9-色氨酸(邻硝基苯基亚磺酰基)]-促肾上腺皮质激素-(1-24)-二十四肽(125I-NPS-ACTH-1-24)的降解与125I-ACTH-1-24相似,但125I-促肾上腺皮质激素-(11-24)-十四肽(125I-ACTH-11-24)的降解受到ACTH-1-24和促肾上腺皮质激素-(1-10)-十肽(ACTH-1-10)的抑制,而相同摩尔浓度的ACTH-11-24则没有作用。另一方面,125I-ACTH-11-24的降解受到ACTH-11-24和ACTH-1-24的保护,但不受ACTH-1-10的保护。这表明存在两种降解系统,一种以ACTH-1-24的NH2末端序列为底物,另一种以11-24的COOH末端序列为底物。125I-ACTH-1-24和125I-ACTH-11-24降解的主要标记产物在Sephadex G-50和纸层析上表现为[125I]单碘酪氨酸。ACTH与其受体结合和降解的独立性由以下事实证明。(a)钙和胰腺胰蛋白酶抑制剂在不改变降解的浓度下完全抑制结合;(b)抑制125I-ACTH-1-24结合和降解的ACTH肽序列不同。